Alexander Jordan Blood, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hypercholesterolemia | 1 | 2023 | 1151 | 0.540 |
Why?
|
| Hip Fractures | 1 | 2023 | 955 | 0.520 |
Why?
|
| Heart Failure | 5 | 2023 | 10905 | 0.490 |
Why?
|
| Aortic Valve Stenosis | 1 | 2023 | 1965 | 0.390 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2024 | 2208 | 0.350 |
Why?
|
| Patient Admission | 1 | 2017 | 1380 | 0.350 |
Why?
|
| Diabetes Complications | 1 | 2016 | 1361 | 0.330 |
Why?
|
| Hypertension | 3 | 2023 | 8480 | 0.320 |
Why?
|
| Lipid Metabolism | 1 | 2016 | 1888 | 0.300 |
Why?
|
| Cardiovascular Diseases | 3 | 2024 | 15161 | 0.280 |
Why?
|
| Delivery of Health Care | 2 | 2023 | 5319 | 0.230 |
Why?
|
| Telemedicine | 2 | 2020 | 2872 | 0.220 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 2 | 2020 | 3256 | 0.210 |
Why?
|
| Pharmacists | 1 | 2024 | 247 | 0.200 |
Why?
|
| Negotiating | 1 | 2022 | 133 | 0.200 |
Why?
|
| National Library of Medicine (U.S.) | 1 | 2020 | 35 | 0.190 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2024 | 11732 | 0.190 |
Why?
|
| Information Storage and Retrieval | 1 | 2022 | 824 | 0.140 |
Why?
|
| Cardiomyopathy, Dilated | 1 | 2021 | 851 | 0.120 |
Why?
|
| Medical Informatics | 1 | 2021 | 743 | 0.120 |
Why?
|
| Insurance, Health, Reimbursement | 1 | 2017 | 397 | 0.120 |
Why?
|
| Arrhythmias, Cardiac | 1 | 2023 | 2267 | 0.110 |
Why?
|
| Cholesterol, LDL | 1 | 2023 | 2355 | 0.110 |
Why?
|
| Disease Management | 1 | 2024 | 2458 | 0.110 |
Why?
|
| Stroke Volume | 3 | 2021 | 5008 | 0.110 |
Why?
|
| Overweight | 1 | 2023 | 2370 | 0.110 |
Why?
|
| Inpatients | 1 | 2023 | 2518 | 0.100 |
Why?
|
| Blood Pressure | 2 | 2023 | 8551 | 0.090 |
Why?
|
| Patient Transfer | 1 | 2017 | 761 | 0.090 |
Why?
|
| Hospital Mortality | 1 | 2023 | 5316 | 0.090 |
Why?
|
| Electronic Health Records | 2 | 2022 | 4463 | 0.080 |
Why?
|
| Kidney | 1 | 2024 | 7183 | 0.080 |
Why?
|
| Humans | 15 | 2024 | 744220 | 0.070 |
Why?
|
| Practice Guidelines as Topic | 2 | 2020 | 7281 | 0.070 |
Why?
|
| Incidence | 1 | 2023 | 20945 | 0.060 |
Why?
|
| Registries | 1 | 2020 | 8090 | 0.060 |
Why?
|
| Clinical Trials as Topic | 1 | 2020 | 7908 | 0.060 |
Why?
|
| Health Care Costs | 1 | 2017 | 3209 | 0.060 |
Why?
|
| Risk Factors | 2 | 2023 | 72280 | 0.060 |
Why?
|
| Research Design | 1 | 2019 | 5987 | 0.060 |
Why?
|
| Longitudinal Studies | 1 | 2019 | 13990 | 0.060 |
Why?
|
| Aged | 5 | 2023 | 163253 | 0.060 |
Why?
|
| Patient Readmission | 1 | 2017 | 3114 | 0.060 |
Why?
|
| Algorithms | 2 | 2020 | 13885 | 0.050 |
Why?
|
| Informatics | 1 | 2022 | 72 | 0.050 |
Why?
|
| Coronary Artery Disease | 1 | 2021 | 6489 | 0.050 |
Why?
|
| Blood Pressure Monitoring, Ambulatory | 1 | 2023 | 236 | 0.050 |
Why?
|
| Postoperative Complications | 1 | 2023 | 15294 | 0.050 |
Why?
|
| Biology | 1 | 2022 | 294 | 0.050 |
Why?
|
| Colchicine | 1 | 2020 | 243 | 0.040 |
Why?
|
| Automation | 1 | 2021 | 584 | 0.040 |
Why?
|
| Female | 6 | 2023 | 380197 | 0.040 |
Why?
|
| Male | 5 | 2023 | 350027 | 0.040 |
Why?
|
| Retrospective Studies | 2 | 2023 | 77426 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2019 | 39045 | 0.040 |
Why?
|
| Workflow | 1 | 2021 | 847 | 0.040 |
Why?
|
| Middle Aged | 5 | 2023 | 213367 | 0.040 |
Why?
|
| Databases, Factual | 2 | 2022 | 7730 | 0.030 |
Why?
|
| Career Choice | 1 | 2022 | 744 | 0.030 |
Why?
|
| Vasodilator Agents | 1 | 2020 | 977 | 0.030 |
Why?
|
| Renin-Angiotensin System | 1 | 2020 | 759 | 0.030 |
Why?
|
| Treatment Outcome | 2 | 2020 | 63119 | 0.030 |
Why?
|
| Cardiovascular Agents | 1 | 2020 | 850 | 0.030 |
Why?
|
| Fibrosis | 1 | 2021 | 2029 | 0.030 |
Why?
|
| Patient-Centered Care | 1 | 2023 | 1438 | 0.030 |
Why?
|
| Patient Participation | 1 | 2020 | 1457 | 0.020 |
Why?
|
| Fibrinolytic Agents | 1 | 2020 | 2158 | 0.020 |
Why?
|
| Extracorporeal Membrane Oxygenation | 1 | 2020 | 1356 | 0.020 |
Why?
|
| Patient Discharge | 1 | 2021 | 3313 | 0.020 |
Why?
|
| Attitude of Health Personnel | 1 | 2022 | 3842 | 0.020 |
Why?
|
| Combined Modality Therapy | 1 | 2020 | 8628 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2021 | 8321 | 0.020 |
Why?
|
| Hypoglycemic Agents | 1 | 2020 | 2875 | 0.020 |
Why?
|
| Ventricular Function, Left | 1 | 2021 | 3669 | 0.020 |
Why?
|
| Aged, 80 and over | 2 | 2021 | 57768 | 0.020 |
Why?
|
| Body Mass Index | 1 | 2023 | 12718 | 0.020 |
Why?
|
| Predictive Value of Tests | 1 | 2021 | 15070 | 0.020 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2020 | 9960 | 0.010 |
Why?
|
| Adult | 3 | 2023 | 214035 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2020 | 21752 | 0.010 |
Why?
|
| Pandemics | 1 | 2023 | 8387 | 0.010 |
Why?
|
| Obesity | 1 | 2023 | 12742 | 0.010 |
Why?
|
| Young Adult | 1 | 2023 | 56436 | 0.010 |
Why?
|
| United States | 1 | 2020 | 69867 | 0.010 |
Why?
|